NAN Nanosonics Limited

—Mkt Cap: —P/E: —

Nanosonics Limited engages in the manufacture and commercialization of infection control and decontamination products and related technologies in Australia, North America, Europe, the United Kingdom, the Middle East, and…

Key Statistics

Company
Market Cap—
Enterprise Value487.12M USD
Revenue (TTM)140.91M USD
Gross Profit108.37M USD
Net Income (TTM)12.33M USD
Revenue/Share0.67 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees508
CountryAU
SectorHealthcare
IndustryMedical Devices & Supplies
ISINAU000000NAN9
Valuation
P/E (Trailing)—
P/E (Forward)53.94
PEG46.36
EV/EBITDA31.88
EV/Revenue3.46
P/S4.12
P/B3.85
EPS (TTM)0.06
EPS (Forward)0.05
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin76.91%
Oper. Margin7.67%
EBITDA Margin10.85%
Profit Margin8.75%
ROE8.20%
ROA5.90%
Growth
Revenue Growth-3.20%
Earnings Growth-24.90%
Cash Flow & Leverage
Operating CF15.58M USD
CapEx (TTM)3.55M USD
FCF Margin-0.04%
FCF Yield—
Net Debt-91.29M USD
Net Debt/EBITDA-5.97
Balance Sheet
Debt/Equity0.11
Current Ratio5.56
Quick Ratio4.67
Book Value/Sh0.73 AUD
Cash/Share0.52 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)3.881 AUD
Target Range3.200 AUD – 5.150 AUD
# Analysts7
Ownership
Shares Out.299.17M
Float274.49M
Insiders8.46%
Institutions60.62%
Technical
SMA 503.029 AUD
SMA 2003.373 AUD
Beta1.15
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)967.32K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—